Pharmacodynamic monitoring of the immunosuppressive therapy in patients after heart transplantation: Whole blood flow cytometric analysis of lymphocyte function

Computers in Biology and Medicine

Volumn 37, Issue 10, 2007, Pages 1367-1373

  Barten, Markus J ^a   Rahmel, Axel ^a   Boldt, Andreas ^a   Dhein, Stefan ^a   Bittner, Hartmuth B ^a   Tarnok, Attila ^a   Mohr, Friedrich W ^a   Gummert, Jan F ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Flow cytometry; Immunosuppression; Lymphocyte function; Pharmacodynamic; Pharmacokinetic; Whole blood

Indexed keywords

BLOOD; CELLS; DRUG INTERACTIONS; FLOW CYTOMETRY; PATIENT MONITORING; PHARMACOKINETICS; TRANSPLANTATION (SURGICAL);

IMMUNOSUPPRESSIVE THERAPY; LYMPHOCYTES; WHOLE BLOOD FLOW CYTOMETRIC ANALYSIS;

IMMUNOLOGY;

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLOW CYTOMETRY; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; MALE; PHARMACODYNAMICS; PRIORITY JOURNAL;

AGED; CELL PROLIFERATION; CYCLOSPORINE; DATA INTERPRETATION, STATISTICAL; FEMALE; FLOW CYTOMETRY; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; SAFETY;

EID: 34547559268     PISSN: 00104825     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2006.11.001     Document Type: Article

References (23)

1. Kahan B.D. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clin. Ther. 24 (2002) 330
2. Levy G. Concentration- or effect-controlled clinical trials with sparse data. Clin. Pharmacol. Ther. 56 (1994) 1
3. Gummert J.F. Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology. Transplantation 70 (2000) 1038
4. Gummert J.F. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. J. Pharmacol. Exp. Ther. 291 (1999) 1100
5. Barten M.J. Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro. J. Immunol. Methods 253 (2001) 95
6. Barten M.J. Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo. Transplant. Immunol. 10 (2002) 1
7. Barten M.J. Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection. Am. J. Transplant. 2 (2002) 719
8. Barten M.J. Synergistic effects of sirolimus and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in whole blood. Transplantation 77 (2004) 1154
9. M.J. Barten, Comparative immunosuppressive activities of cyclosporine, tacrolimus and mycophenolate mofetil: pharmacodynamics after mono and combination drug therapy, Ther. Drug Monitoring 27 (2005) 123.
10. Barten M.J. Assessment of immunosuppressive drug interaction: inhibition of lymphocyte function in peripheral human blood. J. Immunol. Methods 283 (2003) 99
11. Suni M.A. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J. Immunol. Methods 212 (1998) 89
12. Cantarovich M. Clinical benefit of Neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients. Transplantation 68 (1999) 1839
13. Dambrin C. Pharmacodynamics of immunosuppressive drugs. Curr. Opin. Immunol. 12 (2000) 557
14. Awni W.M. Pharmacodynamic monitoring of cyclosporine. Clin. Pharmacokinet. 23 (1992) 428
15. Silva H.T. Single- and multiple-dose pharmacokinetics and pharmacodynamics of leflunomide's active metabolite A77 1726 in normal Lewis rats. Transplant. Proc. 28 (1996) 3092
16. Batiuk T.D. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. Transplantation 59 (1995) 1400
17. Gallant H.L. P70 S6 kinase assay: a pharmacodynamic monitoring strategy for rapamycin assay development. Transplant. Proc. 28 (1996) 3058
18. Halloran P.F. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 68 (1999) 1356
19. Budde K. Pharmacodynamic monitoring of mycophenolate mofetil. Clin. Chem. Lab. Med. 38 (2000) 1213
20. van den Berg A.P. Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production. Transplantation 65 (1998) 1066
21. Stalder M. Quantification of immunosuppression by flow cytometry in stable renal transplant recipients. Ther. Drug Monit. 25 (2003) 22
22. Weigel G. Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients. J. Heart Lung Transplant. 21 (2002) 1074
23. Hartel C. Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression. Clin. Chem. 48 (2002) 2225